156 related articles for article (PubMed ID: 7538057)
41. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber.
Ono S; Tsujimoto H; Matsumoto A; Ikuta S; Kinoshita M; Mochizuki H
Am J Surg; 2004 Aug; 188(2):150-6. PubMed ID: 15249240
[TBL] [Abstract][Full Text] [Related]
42. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10.
Skrzeczyńska-Moncznik J; Bzowska M; Loseke S; Grage-Griebenow E; Zembala M; Pryjma J
Scand J Immunol; 2008 Feb; 67(2):152-9. PubMed ID: 18201370
[TBL] [Abstract][Full Text] [Related]
43. Reduced CD4 and HLA-DR expression in neonatal monocytes.
Kampalath B; Cleveland RP; Kass L
Clin Immunol Immunopathol; 1998 Apr; 87(1):93-100. PubMed ID: 9576015
[TBL] [Abstract][Full Text] [Related]
44. Long-term continuous ambulatory peritoneal dialysis reduces the expression of CD11b, CD14, CD16, and CD64 on peritoneal macrophages.
Cárcamo C; Fernández-Castro M; Selgas R; Jiménez C; Molina S; Vara F
Perit Dial Int; 1996; 16(6):582-9. PubMed ID: 8981525
[TBL] [Abstract][Full Text] [Related]
45. Expression of activation markers on alveolar macrophages in allergic asthmatics after endobronchial or whole-lung allergen challenge.
Viksman MY; Bochner BS; Peebles RS; Schleimer RP; Liu MC
Clin Immunol; 2002 Jul; 104(1):77-85. PubMed ID: 12139951
[TBL] [Abstract][Full Text] [Related]
46. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
[TBL] [Abstract][Full Text] [Related]
47. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
Kawanaka N; Yamamura M; Aita T; Morita Y; Okamoto A; Kawashima M; Iwahashi M; Ueno A; Ohmoto Y; Makino H
Arthritis Rheum; 2002 Oct; 46(10):2578-86. PubMed ID: 12384915
[TBL] [Abstract][Full Text] [Related]
48. Increases in inflammatory and CD14
Gainaru G; Papadopoulos A; Tsangaris I; Lada M; Giamarellos-Bourboulis EJ; Pistiki A
Crit Care; 2018 Mar; 22(1):56. PubMed ID: 29499723
[TBL] [Abstract][Full Text] [Related]
49. CD14+ CD16+ monocytes rather than CD14+ CD51/61+ monocytes are a potential cytological marker of circulating osteoclast precursors in multiple myeloma. A preliminary study.
Petitprez V; Royer B; Desoutter J; Guiheneuf E; Rigolle A; Marolleau JP; Kamel S; Guillaume N
Int J Lab Hematol; 2015 Feb; 37(1):29-35. PubMed ID: 24661393
[TBL] [Abstract][Full Text] [Related]
50. CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy.
Scherberich JE; Nockher WA
Clin Chem Lab Med; 1999 Mar; 37(3):209-13. PubMed ID: 10353463
[TBL] [Abstract][Full Text] [Related]
51. Monocyte-macrophage polarization balance in pre-diabetic individuals.
Fadini GP; Cappellari R; Mazzucato M; Agostini C; Vigili de Kreutzenberg S; Avogaro A
Acta Diabetol; 2013 Dec; 50(6):977-82. PubMed ID: 24085683
[TBL] [Abstract][Full Text] [Related]
52. CD14(hi)HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease.
Thiesen S; Janciauskiene S; Uronen-Hansson H; Agace W; Högerkorp CM; Spee P; Håkansson K; Grip O
J Leukoc Biol; 2014 Mar; 95(3):531-41. PubMed ID: 24212097
[TBL] [Abstract][Full Text] [Related]
53. Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantation.
Ino K; Bierman PJ; Varney ML; Heimann DG; Kuszynski CA; Walker SA; Talmadge JE
Cancer Immunol Immunother; 1996 Dec; 43(4):206-12. PubMed ID: 9003465
[TBL] [Abstract][Full Text] [Related]
54. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
[TBL] [Abstract][Full Text] [Related]
55. Circulating CD14+ and CD14
Ammirati E; Moroni F; Magnoni M; Di Terlizzi S; Villa C; Sizzano F; Palini A; Garlaschelli K; Tripiciano F; Scotti I; Catapano AL; Manfredi AA; Norata GD; Camici PG
Atherosclerosis; 2016 Dec; 255():171-178. PubMed ID: 27751505
[TBL] [Abstract][Full Text] [Related]
56. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity.
Merino A; Buendia P; Martin-Malo A; Aljama P; Ramirez R; Carracedo J
J Immunol; 2011 Feb; 186(3):1809-15. PubMed ID: 21191073
[TBL] [Abstract][Full Text] [Related]
57. A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages.
Lagrange B; Martin RZ; Droin N; Aucagne R; Paggetti J; Largeot A; Itzykson R; Solary E; Delva L; Bastie JN
Biochim Biophys Acta; 2013 Aug; 1833(8):1936-46. PubMed ID: 23602969
[TBL] [Abstract][Full Text] [Related]
58. Pattern of CD14, CD16, CD163 and CD172a expression on water buffalo (Bubalus bubalis) leukocytes.
Elnaggar MM; Grandoni F; Abdellrazeq GS; Fry LM; El-Naggar K; Hulubei V; Buttazzoni L; Khaliel SA; Torky HA; Davis WC
Vet Immunol Immunopathol; 2019 May; 211():1-5. PubMed ID: 31084887
[TBL] [Abstract][Full Text] [Related]
59. Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
Chuluundorj D; Harding SA; Abernethy D; La Flamme AC
Immunol Cell Biol; 2014 Jul; 92(6):509-17. PubMed ID: 24638064
[TBL] [Abstract][Full Text] [Related]
60. Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease.
Grip O; Bredberg A; Lindgren S; Henriksson G
Inflamm Bowel Dis; 2007 May; 13(5):566-72. PubMed ID: 17260384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
